Altersolanol A

Altersolanol A

SCHEMBL8734898

COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 2/20 1.00
▸ NFKB2 Q00653 2/20 1.00
▸ RELA Q04206 2/20 1.00
▸ IDO1 P14902 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.49
▸ ELANE P08246 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ GLA P06280 1/20 0.49
▸ MYLK Q15746 1/20 0.40
▸ POLK Q9UBT6 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CYP3A4 P08684 3/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ AKR1B1 P15121 3/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Altersolanol A SCHEMBL2793105 1.00 NFKB1 (1.00) NFKB1NFKB2RELAIDO1ALDH1A1
Altersolanol A SCHEMBL29688970 1.00 NFKB1 (1.00) NFKB1NFKB2RELAIDO1ALDH1A1
Altersolanol A SCHEMBL14923292 1.00 NFKB1 (1.00) NFKB1NFKB2RELAIDO1ALDH1A1
Altersolanol A SCHEMBL29845341 1.00 NFKB1 (1.00) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL8735134 0.90 NFKB1 (0.82) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL8736848 0.90 NFKB1 (0.82) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL29359598 0.90 NFKB1 (0.82) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL29360149 0.90 NFKB1 (0.82) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL6114092 0.85 NFKB1 (0.74) NFKB1NFKB2RELAIDO1ALDH1A1
SCHEMBL3785760 0.85 NFKB1 (0.74) NFKB1NFKB2RELAIDO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435394-B1 NOVEL ANTHRAQUINONE DERIVATIVES SEALIFE PHARMA GMBH (AT) 2013-05-08 — — EP disclosed
US-20120129927-A1 New Anthraquinone Derivatives SEALIFE PHARMA GMBH (AT) 2012-05-24 — — US disclosed
US-20120129927-A1 New Anthraquinone Derivatives SEALIFE PHARMA GMBH (AT) 2012-05-24 — — US disclosed
WO-2010135759-A1 NOVEL ANTHRAQUINONE DERIVATIVES SEALIFE PHARMA GMBH (AT) 2010-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129927-A1 New Anthraquinone Derivatives ANXA1, ANTXR2, ANXA11 NFKB1 1413/4885NFKB2 1824/4885RELA 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback